Number one: the last transaction#
Nobody sets a stock price. There’s no committee. Price emerges from the order book — a live list of bids (what buyers will pay) and asks (what sellers will accept), updating in milliseconds.
The figure your app displays is simply the last completed transaction. Past tense. If buyers are eager they bid higher to attract sellers and the price climbs. If sellers are frightened by news they cut their asks to find buyers quickly and it drops. Pure supply and demand, executed mechanically.
Number two: what you’d actually pay#
Which is not the displayed price. To buy right now, you transact against the current asks, not against the last trade.
On something liquid the difference is a rounding error. On a thinly traded stock or a niche ETF the bid-ask spread is a genuine cost, and you pay it twice — entering and exiting. It never appears in any expense ratio.
Two numbers so far, and neither has anything to do with whether the business is any good.
Number three: what it’s worth#
Intrinsic value is what the company is rationally worth based on earnings, assets and growth prospects, with hype and panic stripped out.
The essential caveat comes first, because everything after it depends on it: intrinsic value is an estimate, not a fact. Two competent analysts applying identical methods produce different numbers. It isn’t weighing apples. It’s guessing what the apples will sell for next year.
Four methods do most of the work.
Discounted cash flow. Project future cash profits, then discount them to today, because future money is worth less than present money. A company generating $100 a year for three years at a 10% discount rate gives you roughly $91, $83 and $75 in today’s terms. Add a terminal value — say $1,000 discounted to $751 — and you get about $1,000 total. Across 100 shares, that’s $10 a share. Trading at $8, potentially undervalued; at $12, potentially over.
Dividend discount model. Same discounting logic, applied to dividends instead of cash flows. A stock paying $2 a share growing 5% a year has a calculable present value. Works for stable payers like utilities; useless for anything that doesn’t distribute.
Asset-based valuation. Total assets minus total liabilities, divided by share count. $500M in assets against $200M of debt gives $300M. Best for asset-heavy businesses — property firms, banks, manufacturers.
Earnings multiple. Earnings per share times an industry-typical multiple. If tech trades at 20x and the company earns $5 a share, that’s $100. Fastest and least reliable, since it inherits whatever mispricing exists in the comparison set.
Why the market ignores all four#
Most stocks don’t trade at intrinsic value, and the gap is usually deliberate rather than mistaken.
Sentiment bids prices above fundamentals when a story is exciting.
Future expectations are the big one. Growth companies are priced on profits expected years out, not current earnings. Tesla traded far above any defensible intrinsic value calculation for years — buyers weren’t valuing the current income statement, they were pricing a bet on technology and scale. Calling that “irrational” misses what the transaction was.
The macro environment shifts everything at once. When interest rates sat near zero from 2020 to 2022, stocks became more attractive relative to bonds, which lifted prices even for companies with weak fundamentals. The discount rate in every DCF model is an interest rate. Move it and every valuation on earth moves.
Where intrinsic value stops helping#
Two blind spots worth knowing.
Startups and unprofitable companies. Run a DCF on a business with no profits and you’ll calculate something near zero while the stock trades at $40. The model isn’t broken; it’s answering a question about current cash flows when the market is asking a question about future ones.
High-growth tech and biotech. Same problem. Today’s earnings don’t describe what investors are betting on.
And the timing caveat that has broken more disciplined investors than any other: the market can ignore intrinsic value for years. Being right about a valuation and being right about a price are different achievements with different timelines.
What it’s actually for#
Given all that, is intrinsic value useful? Yes — as a lens, not a predictor.
Value investing rests on buying below intrinsic value and holding while the gap closes. Buffett’s framing is the useful one: investing is like buying a farm, where you assess soil and crops rather than what the neighbour paid yesterday. The calculation isn’t a price target. It’s a discipline that forces you to articulate what you think the business produces before you form an opinion about the ticker.
That’s the real payoff. Not precision — a habit of separating the three numbers instead of letting the screen do your thinking.
Summary — and what to do about it#
Price, cost and value are three separate numbers, and the app shows you the least informative one.
- Read the displayed price as history. It’s the last completed trade, not an offer.
- Check the spread before buying anything thinly traded. You pay it on the way in and the way out.
- Pick the valuation method that fits the business. DCF for stable cash generators, dividend models for reliable payers, asset-based for asset-heavy firms, multiples for a fast comparison.
- Treat every valuation as a range. Same method, same analyst, different assumptions, different answer.
- Check the interest rate environment before concluding something is overvalued. The discount rate moves every valuation simultaneously.
- Never expect the gap to close on your schedule. Markets stay disconnected from fundamentals far longer than most people can hold.
Do the calculation anyway. Not because it’s accurate, but because you can’t be talked into something you’ve already priced.
Sources & further reading#
- Nasdaq, “Enterprise Value Formula: What It Is and How to Use It” — valuation inputs beyond share price.
- Eqvista, “Enterprise Value-to-EBITDA” — how multiples-based valuation works in practice.
- Wall Street Mastermind, “EV/EBITDA, EV/Revenue, and P/E explained” — the limitations of earnings-multiple shortcuts.
- Aswath Damodaran’s investment fables — on discounting, dividends and what valuation models can and can’t tell you.
